参考文献：（上下滑动可浏览）
1 stone, j. c., atkinson, t., smith, m. & pawson, t. identification of functional regions in the transforming protein of fujinami sarcoma virus by in-phase insertion mutagenesis. cell 37, 549-558 (1984).
2 sadowski, i., stone, j. c. & pawson, t. a noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of fujinami sarcoma virus p130gag-fps. molecular and cellular biology 6, 4396-4408 (1986).
3 moran, m. f. et al. src homology region 2 domains direct protein-protein interactions in signal transduction. proceedings of the national academy of sciences 87, 8622-8626 (1990).
4 anderson, d. et al. binding of sh2 domains of phospholipase c gamma 1, gap, and src to activated growth factor receptors. science 250, 979-982 (1990).
5 isaacs, a. & lindenmann, j. virus interference. i. the interferon. proceedings of the royal society of london. series b-biological sciences 147, 258-267 (1957).
6 baron, s. et al. the interferons: mechanisms of action and clinical applications. jama 266, 1375-1383 (1991).
7 zinn, k., dimaio, d. & maniatis, t. identification of two distinct regulatory regions adjacent to the human β-interferon gene. cell 34, 865-879 (1983).
8 miyamoto, m. et al. regulated expression of a gene encoding a nuclear factor, irf-1, that specifically binds to ifn-β gene regulatory elements. cell 54, 903-913 (1988).
9 fujita, t. et al. evidence for a nuclear factor (s), irf‐1, mediating induction and silencing properties to human ifn‐beta gene regulatory elements. the embo journal 7, 3397-3405 (1988).
10 derman, e. et al. transcriptional control in the production of liver-specific mrnas. cell 23, 731-739 (1981).
11 clayton, d. f. & darnell, j. changes in liver-specific compared to common gene transcription during primary culture of mouse hepatocytes. molecular and cellular biology 3, 1552-1561 (1983).
12 clayton, d. f., harrelson, a. l. & darnell, j. dependence of liver-specific transcription on tissue organization. molecular and cellular biology 5, 2623-2632 (1985).
13 larner, a. et al. transcriptional induction of two genes in human cells by beta interferon. proceedings of the national academy of sciences 81, 6733-6737 (1984).
14 friedman, r. l., manly, s. p., mcmahon, m., kerr, i. m. & stark, g. r. transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. cell 38, 745-755 (1984).
15 kerr, i. m., brown, r. e. & hovanessian, a. g. nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded rna. nature 268, 540-542 (1977).
16 aguet, m. high-affinity binding of 125 i-labelled mouse interferon to a specific cell surface receptor. nature 284, 459-461 (1980).
17 aguet, m., dembić, z. & merlin, g. molecular cloning and expression of the human interferon-γ receptor. cell 55, 273-280 (1988).
18 levy, d., larner, a., chaudhuri, a., babiss, l. & darnell, j. interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. proceedings of the national academy of sciences 83, 8929-8933 (1986).
19 kessler, d., pine, r., pfeffer, l., levy, d. & darnell jr, j. cells resistant to interferon are defective in activation of a promoter‐binding factor. the embo journal 7, 3779-3783 (1988).
20 levy, d. e., kessler, d. s., pine, r., reich, n. & darnell, j. interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. genes & development 2, 383-393 (1988).
21 friedman, r. l. & stark, g. r. α-interferon-induced transcription of hla and metallothionein genes containing homologous upstream sequences. nature 314, 637-639 (1985).
22 porter, a. et al. interferon response element of the human gene 6‐16. the embo journal 7, 85-92 (1988).
23 dale, t. c., imam, a., kerr, i. m. & stark, g. r. rapid activation by interferon alpha of a latent dna-binding protein present in the cytoplasm of untreated cells. proceedings of the national academy of sciences 86, 1203-1207 (1989).
24 fu, x., colgan, j. & manley, j. multiple cis-acting sequence elements are required for efficient splicing of simian virus 40 small-t antigen pre-mrna. molecular and cellular biology 8, 3582-3590 (1988).
25 fu, x.-y., ge, h. & manley, j. l. the role of the polypyrimidine stretch at the sv40 early pre‐mrna 3′ splice site in alternative splicing. the embo journal 7, 809-817 (1988).
26 fu, x. & manley, j. l. factors influencing alternative splice site utilization in vivo. molecular and cellular biology 7, 738-748 (1987).
27 fu, x.-y., kessler, d. s., veals, s. a., levy, d. e. & darnell, j. isgf3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. proceedings of the national academy of sciences 87, 8555-8559 (1990).
28 fu, x.-y., schindler, c., improta, t., aebersold, r. & darnell, j. e. the proteins of isgf-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. proceedings of the national academy of sciences 89, 7840-7843 (1992).
29 schindler, c., fu, x.-y., improta, t., aebersold, r. & darnell, j. e. proteins of transcription factor isgf-3: one gene encodes the 91-and 84-kda isgf-3 proteins that are activated by interferon alpha. proceedings of the national academy of sciences 89, 7836-7839 (1992).
30 fu, x.-y. a transcription factor with sh2 and sh3 domains is directly activated by an interferon α-induced cytoplasmic protein tyrosine kinase (s). cell 70, 323-335 (1992).
31 schindler, c., shuai, k., prezioso, v. r. & darnell, j. e. interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. science 257, 809-813 (1992).
32 pellegrini, s., john, j., shearer, m., kerr, i. m. & stark, g. r. use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. mol cell biol 9, 4605-4612, doi:10.1128/mcb.9.11.4605 (1989).
33 wilks, a. f. two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. proc natl acad sci u s a 86, 1603-1607, doi:10.1073/pnas.86.5.1603 (1989).
34 wilks, a. f. et al. two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. mol cell biol 11, 2057-2065, doi:10.1128/mcb.11.4.2057 (1991).
35 velazquez, l., fellous, m., stark, g. r. & pellegrini, s. a protein tyrosine kinase in the interferon αβ signaling pathway. cell 70, 313-322 (1992).
36 darnell, j. e., kerr, i. m. & stark, g. r. jak-stat pathways and transcriptional activation in response to ifns and other extracellular signaling proteins. science 264, 1415-1421 (1994).
37 zhong, z., wen, z. & darnell, j. e., jr. stat3: a stat family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. science 264, 95-98, doi:10.1126/science.8140422 (1994).
38 akira, s. et al. molecular cloning of aprf, a novel ifn-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. cell 77, 63-71 (1994).
39 liu, x., robinson, g. w., gouilleux, f., groner, b. & hennighausen, l. cloning and expression of stat5 and an additional homologue (stat5b) involved in prolactin signal transduction in mouse mammary tissue. proceedings of the national academy of sciences 92, 8831-8835 (1995).
40 schwartz, d. m. et al. jak inhibition as a therapeutic strategy for immune and inflammatory diseases. nat rev drug discov 16, 843-862, doi:10.1038/nrd.2017.201 (2017).
41 taylor, p. c. et al. baricitinib versus placebo or adalimumab in rheumatoid arthritis. n engl j med 376, 652-662, doi:10.1056/nejmoa1608345 (2017).
42 kalil, a. c. et al. baricitinib plus remdesivir for hospitalized adults with covid-19. n engl j med, doi:10.1056/nejmoa2031994 (2020).
43 owen, k. l., brockwell, n. k. & parker, b. s. jak-stat signaling: a double-edged sword of immune regulation and cancer progression. cancers (basel) 11, doi:10.3390/cancers11122002 (2019).
44 qureshy, z., johnson, d. e. & grandis, j. r. targeting the jak/stat pathway in solid tumors. j cancer metastasis treat 6 (2020).
45 nagano, t. pouvoir immunisant du virus vaccinal inactivé par des rayons ultraviolets. compt rend soc biol 148, 1700-1702 (1954).
46 blomstrom, d. c., fahey, d., kutny, r., korant, b. d. & knight jr, e. molecular characterization of the interferon-induced 15-kda protein. molecular cloning and nucleotide and amino acid sequence. journal of biological chemistry 261, 8811-8816 (1986).
47 reich, n. et al. interferon-induced transcription of a gene encoding a 15-kda protein depends on an upstream enhancer element. proceedings of the national academy of sciences 84, 6394-6398 (1987).
48 pine, r., decker, t., kessler, d., levy, d. & darnell, j. purification and cloning of interferon-stimulated gene factor 2 (isgf2): isgf2 (irf-1) can bind to the promoters of both beta interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. molecular and cellular biology 10, 2448-2457 (1990).
49 ge, h. & manley, j. l. a protein factor, asf, controls cell-specific alternative splicing of sv40 early pre-mrna in vitro. cell 62, 25-34 (1990).
50 fu, x.-d. & maniatis, t. factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. nature 343, 437-441 (1990).
